ATYR CIK: 1339970

aTYR PHARMA INC

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
114
FY22:
80.9
FY23:
103
FY24:
82.0
FY25:
80.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.97
FY22:
14.9
FY23:
17.7
FY24:
14.9
FY25:
12.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
116
FY22:
95.8
FY23:
121
FY24:
96.8
FY25:
93.0

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
6.01
FY22:
13.9
FY23:
16.4
FY24:
15.0
FY25:
15.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.40
FY22:
10.6
FY23:
13.8
FY24:
12.0
FY25:
10.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
109
FY22:
71.5
FY23:
90.7
FY24:
70.0
FY25:
67.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
116
FY22:
96.0
FY23:
121
FY24:
97.0
FY25:
93.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data